We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NESR
2151
National Energy Services Reunited Corp
NESR
$2.71B
$12.3K ﹤0.01%
785
HFWA icon
2152
Heritage Financial
HFWA
$1.22B
$12.2K ﹤0.01%
514
+448
+679% +$10.5K
BHC icon
2153
Bausch Health
BHC
$1.67B
$12.2K ﹤0.01%
1,749
+964
+123% +$6.34K
FBIZ icon
2154
First Business Financial Services
FBIZ
$564M
$12.1K ﹤0.01%
223
+66
+42% +$3.45K
DKNG icon
2155
DraftKings
DKNG
$12B
$12.1K ﹤0.01%
351
-239
-41% -$7.86K
PRTA icon
2156
Prothena Corp
PRTA
$455M
$12K ﹤0.01%
1,260
ZBH icon
2157
Zimmer Biomet
ZBH
$17.8B
$12K ﹤0.01%
133
-4,635
-97% -$439K
CTO
2158
CTO Realty Growth
CTO
$744M
$11.9K ﹤0.01%
648
-1,893
-74% -$32.4K
SCSC icon
2159
Scansource
SCSC
$1.13B
$11.9K ﹤0.01%
305
CSV icon
2160
Carriage Services
CSV
$635M
$11.8K ﹤0.01%
280
CMPR icon
2161
Cimpress
CMPR
$2.41B
$11.8K ﹤0.01%
177
ARVN icon
2162
Arvinas
ARVN
$530M
$11.7K ﹤0.01%
987
SWBI icon
2163
Smith & Wesson
SWBI
$666M
$11.7K ﹤0.01%
1,186
+1,015
+594% +$9.8K
NOBL icon
2164
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.8B
$11.7K ﹤0.01%
224
WRLD icon
2165
World Acceptance Corp
WRLD
$909M
$11.7K ﹤0.01%
83
JBSS icon
2166
John B. Sanfilippo & Son
JBSS
$978M
$11.6K ﹤0.01%
165
-59
-26% -$4.01K
IYG icon
2167
iShares US Financial Services ETF
IYG
$2.16B
$11.6K ﹤0.01%
126
RC
2168
Ready Capital
RC
$265M
$11.6K ﹤0.01%
5,319
+4,329
+437% +$12.1K
IVR icon
2169
Invesco Mortgage Capital
IVR
$762M
$11.6K ﹤0.01%
1,377
+344
+33% +$2.7K
ANGO icon
2170
AngioDynamics
ANGO
$565M
$11.5K ﹤0.01%
894
-18
-2% -$222
EVH icon
2171
Evolent Health
EVH
$429M
$11.4K ﹤0.01%
2,843
+1,412
+99% +$7.85K
HESM icon
2172
Hess Midstream
HESM
$5.11B
$11.3K ﹤0.01%
328
GEVO icon
2173
Gevo
GEVO
$380M
$11.3K ﹤0.01%
5,656
BTBT icon
2174
Bit Digital
BTBT
$477M
$11.3K ﹤0.01%
5,952
-1,950
-25% -$5.64K
ORRF icon
2175
Orrstown Financial Services
ORRF
$836M
$11.2K ﹤0.01%
317
+67
+27% +$2.34K

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.